Evidence map›Paper›PMID 34866536›Full record

ArticleDrug delivery2021

Cyclodextrin metal-organic framework as vaccine adjuvants enhances immune responses.

Congcong Li, Chaoxi Chen, Yucai Wei, Min Tan, Shuo Zhai, Juebo Zhao, Lu Wang, Tao Dai

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. In vivo safety evaluation method for nanomaterials for cancer therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  7. Review
  8. Application of Cyclodextrin for Cancer Immunotherapy.Molecules (Basel, Switzerland) · 2023
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Congcong LiCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Chaoxi ChenCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Yucai WeiCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Min TanCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Shuo ZhaiCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Juebo ZhaoCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Lu WangCollege of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu, China.
Tao DaiCollege of Chemistry & Environment, Southwest Minzu University, Chengdu, China.ORCID 0000-0002-6702-888X
Southwest Minzu University · CNQinghai Tibetan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is urgently needed to develop novel adjuvants for improving the safety and efficacy of vaccines. Metal-organic frameworks (MOFs), with high surface area, play an important role in drug delivery. With perfect biocompatibility and green preparation process, the γ-cyclodextrin metal-organic framework (γ-CD-MOF) fabricated with cyclodextrin and potassium suitable for antigen delivery. In this study, we modified γ-CD-MOF with span-85 to fabricate the SP-γ-CD-MOF as animal vaccine adjuvants. The ovalbumin (OVA) as the model antigen was encapsulated into particles to investigate the immune response. SP-γ-CD-MOF displayed excellent biocompatibility

Indexed as

Adjuvants, VaccineAnimalsAnimals, Outbred StrainsBone Marrow CellsCell SurvivalChemistry, PharmaceuticalCytokinesFemalegamma-CyclodextrinsHemolysisImmunoglobulin GMetal-Organic FrameworksMiceOvalbuminRandom AllocationRAW 264.7 CellsAdjuvants, VaccineCytokinesgamma-cyclodextringamma-CyclodextrinsImmunoglobulin GMetal-Organic FrameworksOvalbuminimmune responsesvaccine adjuvantsγ-cyclodextrin metal-organic framework

Identifiers

PMID34866536
PMCPMC8741229
OpenAlexW4200089673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.